Producing an Anti‐dsDNA Antibody Reference Reagents to Calibrate Different Quantitative Assays in China

Jiangfeng Zhao(Shanghai Jiao Tong University), Kaiwen Wang(Fudan University), Canchen Ma(Shanghai Jiao Tong University), Xueyu Zhang(Shanghai Clinical Research Center), Yuqing Zhu(Shanghai Clinical Research Center), Shuang Ye(Little Swan (China)), Li Guo(Shanghai Jiao Tong University), Haiting Yang(Jiading District Central Hospital)
International Journal of Rheumatic Diseases
July 1, 2025
10.1111/1756-185x.70364
Cited by 0

Related Papers

Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
|Clinical Reviews in Allergy & Immunology|2021|210
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications
|Nature Communications|2022|112
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
|Patient Preference and Adherence|2018|111
CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease
|Lara D. Veeken|2018|60
Effectiveness and safety of tofacitinib<i>versus</i>calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort study
|European Respiratory Journal|2025|48